Abstract
We retrospectively analyzed the treatment outcomes of elderly patients (aged ≥ 60 years) with extranodal natural killer/T-cell lymphoma, nasal type (ENKTL) and investigated the prognostic factors. Fifty-two elderly patients received chemotherapy alone, radiotherapy alone, or chemotherapy followed by radiotherapy ± consolidation chemotherapy as induction therapy. Overall, 97.26% patients in stage I/II had overall response (OR) and 86.1% had complete response (CR), whereas 71.4% of patients in stage III/IV had OR and 35.7% had CR. The 3-year freedom from progression (FFP) rate and overall survival (OS) rate of patients with stage I/II were 78.2% and 85.0%, respectively, and those with stage III/IV were 23.3% and 33.3%. Following multivariate analysis of Cox regression, ECOG performance status scores of 3-4 and stage III/IV were independent prognostic factors for elderly ENKTL patients. Elderly patients with stage I/II or stage III/IV and good or poor performance status can benefit from the commonly used or personalized treatment.
References
Oct 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Motoko YamaguchiRitsuro Suzuki
Dec 6, 2011·Cancer·Ming JiangLiqun Zou
Jul 20, 2012·Cancer·Liang WangZhong-jun Xia
Aug 25, 2012·Blood·Yok-Lam KwongChor-Sang Chim
Mar 22, 2014·Molecular and Clinical Oncology·Wanzhuo XieHe Huang
Jul 6, 2014·Leukemia & Lymphoma·Hua WangZhong-Jun Xia
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Feb 18, 2015·Annals of Hematology·Xi-Wen BiZhi-Ming Li
May 11, 2015·Annals of Hematology·Xi-wen BiZhi-ming Li
May 23, 2015·International Journal of Hematology·Hao DingRong Tao
Dec 4, 2015·Cancer Medicine·Li ZhangLi-qun Zou
Jan 5, 2016·Leukemia & Lymphoma·Li-Hua DongYu-Fu Li
Feb 13, 2016·Medicine·Jing-Jing WangYuan-Kai Shi
Feb 14, 2016·The Lancet Oncology·Seok Jin KimWon Seog Kim
Apr 20, 2016·Oncotarget·Jing-Hua WangYue Lu
Dec 6, 2016·Hematology·Wen WeiZhi-Hui Zhang
Apr 16, 2017·Journal of Hematology & Oncology·Eric Tse, Yok-Lam Kwong
Jul 19, 2017·Leukemia & Lymphoma·Alexis D LealCarrie A Thompson
Oct 6, 2017·Leukemia & Lymphoma·Chang SuRong Xiao
Dec 2, 2017·European Journal of Haematology·Ji-Wei LiPing-Yong Yi
Apr 1, 2018·Blood·Motoko YamaguchiMasahiko Oguchi
Dec 21, 2018·Journal of Hematology & Oncology·Seok Jin KimWon Seog Kim
Apr 4, 2019·Journal of Geriatric Oncology·Kitsada WudhikarnUNKNOWN Thai Lymphoma Study Group